MRK
Merck & Company Inc
148.10$
-1.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 33.2% | 29.3% | 32.1% | 28.2% | 31.3% | 32.6% | 30.3% | 28.6% | 32.7% | 30.2% | 33.1% | 31.8% | |
| 7.6% | 8.4% | 6.8% | 6.9% | 9.6% | 11.5% | 8.8% | 7.7% | 11.6% | 6.4% | 11.3% | 10.6% | |
| 16.0% | 13.2% | 15.0% | 9.7% | 10.7% | 12.4% | 8.8% | 7.7% | 12.1% | 6.6% | 11.7% | 10.6% | |
| 6.7% | 6.4% | 7.4% | 7.8% | 8.6% | 8.0% | 7.4% | 8.7% | 8.7% | 9.7% | 8.8% | 9.3% | |
| 5.7% | 4.6% | 5.1% | 5.8% | 6.6% | 7.1% | 6.1% | 5.6% | 5.4% | 6.0% | 5.2% | 4.9% | |
| 13.4% | 12.3% | 12.6% | 14.2% | 16.1% | 17.8% | 19.6% | 18.2% | 19.6% | 23.0% | 21.5% | 19.6% | |
| 13.2% | 17.4% | 19.0% | 20.8% | 22.1% | 23.0% | 20.6% | 20.1% | 19.4% | 19.9% | 18.5% | 15.8% | |
| 20.8% | 22.2% | 18.1% | 16.1% | 15.9% | 16.8% | 15.4% | 21.7% | 18.6% | 16.9% | 14.0% | 19.5% | |
| 50.3% | 56.0% | 57.7% | 60.7% | 67.5% | 69.2% | 72.3% | 63.8% | 57.8% | 64.7% | 60.4% | 61.5% | |
| 18.7% | 18.9% | 18.0% | 21.2% | 26.9% | 26.3% | 29.8% | 22.6% | 22.2% | 24.1% | 24.3% | 20.7% | |
| 2.8% | 2.5% | 0.6% | 3.5% | 6.4% | 4.3% | 7.3% | 2.6% | 2.0% | 1.6% | 2.5% | 2.1% | |
| 2.7% | 2.5% | 2.9% | 3.5% | 4.0% | 4.4% | 4.7% | 4.4% | 3.9% | 3.7% | 3.5% | 3.2% | |
| 19.0% | 23.5% | 25.5% | 24.3% | 24.0% | 26.9% | 27.7% | 29.0% | 26.3% | 31.6% | 29.4% | 34.2% | |
| 49.6% | 43.9% | 42.0% | 39.1% | 32.3% | 30.7% | 27.6% | 36.1% | 42.1% | 35.2% | 39.5% | 38.4% | |
| 46.9% | 44.6% | 46.3% | 47.1% | 51.5% | 55.2% | 51.7% | 50.8% | 56.0% | 50.5% | 53.9% | 53.4% | |
| 3.0% | 2.8% | 2.9% | 3.1% | 3.2% | 3.1% | 2.8% | 2.4% | 2.3% | 2.4% | 2.2% | 1.8% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.